This summary was created by AI, based on 1 opinions in the last 12 months.
The Ensign Group stock (ENSG-Q) is considered a small-cap with a 23x PE ratio in the healthcare sector. Multiple experts have noted that the shares have seen a notable climb from $30 to $36. This indicates a positive trend in the stock's performance, and the company's position in the healthcare industry may be contributing to its growth. However, further analysis is needed to determine its long-term potential.
The Ensign Group is a American stock, trading under the symbol ENSG-Q on the NASDAQ (ENSG). It is usually referred to as NASDAQ:ENSG or ENSG-Q
In the last year, 1 stock analyst published opinions about ENSG-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for The Ensign Group.
The Ensign Group was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for The Ensign Group.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of The Ensign Group published on Stockchase.
On 2025-01-23, The Ensign Group (ENSG-Q) stock closed at a price of $137.59.
A small-cap with a 23x PE in healthcare. Shares have climbed from $30 to $36.